LEP and metabolic dysfunction-associated steatohepatitis: To define the gene expression profile changes during the progression to NASH, we used hepatic samples from young (16-week-old) and old (48-week-old) mice from three obesity models: hyperphagic ob/ob and db/db mice with disruption of leptin signalling and wt C57BL/6J mice fed a HFD.